Related Experiment Video
Updated: Jul 24, 2025
07:59
Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
11.2K
Ultrafiltration in Heart Failure: A Review.
Himanshi Bisht1, Apoorva Tripathi1, Akshat Arya2
1Medicine, Byramjee Jeejeebhoy (BJ) Medical College, Ahmedabad, IND.
Cureus
|July 6, 2023
Summary
Ultrafiltration effectively removes fluid in acute decompensated heart failure patients. While its mortality benefits require more research, it offers an alternative for diuretic-resistant congestion.
Area of Science:
- Cardiology
- Nephrology
- Critical Care Medicine
Background:
- Acute decompensated heart failure (ADHF) frequently causes volume overload and congestion.
- Diuretics are standard treatment but can lose efficacy due to resistance and renal dysfunction.
- Ultrafiltration presents an alternative for managing fluid overload unresponsive to medical therapy.
Purpose of the Study:
- To evaluate ultrafiltration as a treatment for fluid retention in ADHF.
- To compare the efficacy of ultrafiltration with diuretics.
- To explore the limitations and future potential of ultrafiltration in HF management.
Main Methods:
- Systematic review of published clinical trials.
- Comparative analysis of studies on ultrafiltration versus diuretics.
- Literature review on ultrafiltration's shortcomings and advancements.
Main Results:
- Ultrafiltration effectively removes fluid without significantly impacting circulating volume.
- Evidence suggests ultrafiltration may reduce future decompensation episodes.
- Conclusive data on ultrafiltration's superiority in improving mortality is lacking.
Conclusions:
- Ultrafiltration is a viable option for managing refractory congestion in ADHF.
- Further research, particularly mechanistic studies, is needed to clarify ultrafiltration's role in HF mortality.
- Optimal fluid management strategies for ADHF require continued investigation.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
01:22Heart Failure Drugs: Diuretics
424
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
424
01:30Heart Failure V: Medical Management
15
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
15
01:29Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
01:30Continuous Renal Replacement Therapy
54
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
54
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467